SOPHiA GENETICS SA (SOPH)

$2.64

-0.11 (-4.00%)
Rating:
Recommendation:
-
Symbol SOPH
Price $2.64
Beta 0.000
Volume Avg. 0.08M
Market Cap 169.366M
Shares () -
52 Week Range 2.16-18.24
1y Target Est -
DCF Unlevered SOPH DCF ->
DCF Levered SOPH LDCF ->
ROE -58.32% Strong Sell
ROA -16.36% Sell
Operating Margin -
Debt / Equity 18.12% Neutral
P/E -
P/B 0.67 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SOPH news


Healthcare
Health Information Services
NASDAQ Global Select

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.